Retinal arterial changes correlate with cerebral small-vessel disease

Neurology

Volumn 59, Issue 10, 2002, Pages 1536-1540

  Kwa, V I H ^a,b   Van der Sande, J J ^a   Stam, J ^b   Tijmes, N ^a   Vrooland, J L ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERY OCCLUSION; ATHEROSCLEROSIS; BRAIN; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; HUMAN; HYPERTENSION; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOGRAPHY; PRIORITY JOURNAL; RETINA ARTERY; RETINA BLOOD VESSEL OCCLUSION; REVIEW; RISK FACTOR; SCLEROSIS; SCORING SYSTEM; SYMPTOM; WHITE MATTER;

EID: 0037180475     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000033093.16450.5C     Document Type: Review

References (32)

1. Ostrow PT, Miller LL. Pathology of small artery disease. Adv Neurol 1993;62:93-123.
2. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis. A review. Stroke 1997;28:652-659.
3. Fisher CM. Capsular infarcts. The underlying vascular lesions. Arch Neurol 1979;36:65-73.
4. Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke 1996;27:1641-1647.
5. Meguro K, Hatazawa J, Yamaguchi T, et al. Cerebral circulation and oxygen metabolism associated with subcortical hyperintensity as shown by magnetic resonance imaging. Ann Neurol 1990;28:378-383.
6. Newsom RSB, Sullivan PM, Rassam SMB, Jagoe R, Kohner EM. Retinal vessel measurement: Comparison between observer and computer driven methods. Graefes Arch Clin Exp Ophthalmol 1992;230:221-225.
7. Suzuki Y. Direct measurement of retinal vessel diameter: Comparison with microdensitometric methods based on fundus photographs. Surv Ophthalmol 1995;39:S57-S65.
8. Park SS, Sigelman J, Gragoudas ES. Ocular anatomy, embryology, and teratology. The anatomy and cell biology of the retina. In: Tasman W, Jaeger EA, eds. Duane's ophthalmology. CD-ROM ed. Philadelphia: Lippincott-Raven, 1997.
9. Wise GN, Dollery CT, Henkind P. Structure of retinal vessels. In: Wise GN, Dollery CT, Henkind P, eds. The Retinal Circulation. New York: Harper & Row, 1971:33-54.
10. Karesh JW. Topographic anatomy of the eye: An overview. In: Tasman W, Jaeger EA, eds. Duane's Ophthalmology. CD-Rom ed. Philadelphia: Lippincott-Raven, 1997.
11. Kincaid MC, Yanoff M, Fine BS. Retina. Vascular disease. In: Tasman W, Jaeger EA, eds. Duane's ophthalmology. CD-ROM ed. Philadelphia: Lippincott-Raven, 1997.
12. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable sub-types of cerebral infarction. Lancet 1991;337:1521-1526.
13. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJNR 1987;8:421-426.
14. Scheltens P, Barkhof F, Leys D, et al. A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993;114:7-12.
15. Perneger TV. What's wrong with Bonferroni adjustments? Br Med J 1998;316:1236-1238.
16. Kappelle LJ, Koudstaal PJ, van Gijn J, Ramos LM, Keunen JE. Carotid angiography in patients with lacunar infarction. A prospective study. Stroke 1988;19:1093-1096.
17. Luijckx G-J, Boiten J, van Kroonenburgh M, et al. Systemic small-vessel disease is not exclusively related to lacunar stroke. A pilot study. J Stroke Cerebrovasc Dis 1998;7:52-57.
18. Warlow CP, Dennis MS, van Gijn J, et al. Stroke. A Practical Guide to Management. Oxford: Blackwell Science, 1996.
19. Evans A, Perez I, Yu G, Kalra L. Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation? Stroke 2001;32:2828-2832.
20. Ay H, Oliveira-Filho J, Buonanno FS, et al. Diffusion-weighted imaging identifies a subset of lacunar infarction associated with embolic source. Stroke 1999;30:2644-2650.
21. Lodder J, Bamford JM, Sandercock PAG, Jones LN, Warlow CP. Are hypertension or cardiac embolism likely causes of lacunar infarction? Stroke 1990;21:375-381.
22. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 1995; 26:1471-1477.
23. Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 1997;42:857-865.
24. Kwa VIH, Franke CL, Verbeeten B Jr, Stam J, for the Amsterdam Vascular Medicine Group. Silent intracerebral microhemorrhages in patients with ischemic stroke. Ann Neurol 1998;44:372-377.
25. Scheie HG. Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis. Arch Ophthalmol 1953;49: 117-138.
26. Leishman R. The eye in the general vascular disease: Hypertension and arteriosclerosis. Br J Ophthalmol 1957;41:641- 701.
27. Klein R, Sharrett AR, Klein BE, et al. Are retinal arteriolar abnormalities related to atherosclerosis? Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol 2000; 20:1644-1650.
28. Murphy RP, Chew EY. Hypertension. In: Ryan SJ, Schachat AP, Murphy RP, eds. Retina. 2nd ed. St. Louis: Mosby, 1994: 1413-1419.
29. Enstrom I, Burtscher IM, Eskilsson J, et al. Organ damage in treated middle-aged hypertensives compared with normotensives: Results from a cross-sectional study in general practice. Blood Pressure 2000;9:28-33.
30. Nag S. Cerebral changes in chronic hypertension: Combined permeability and immunohistochemical studies. Acta Neuropathol 1984;62:178-184.
31. Fredriksson K, Nordbord C, Kalimo H, Olsson Y, Johansson BB. Cerebral microangiopathy in stroke-prone spontaneously hypertensive rats: An immunohistochemical and ultrastructural study. Acta Neuropathol 1988;75:241-252.
32. Lammie GA, Brannan F, Slattery J, Warlow C. Nonhypertensive cerebral small-vessel disease. An autopsy study. Stroke 1997;28:2222-2229.